Core Insights - Quasar Medical has completed the acquisition of Nordson Corporation's design & development contract manufacturing businesses, enhancing its global CDMO platform and capabilities for medical device OEMs and innovators [1][3]. Company Expansion - The acquisition marks Quasar's evolution into a fully integrated CDMO, providing concept-to-commercialization solutions worldwide and expanding its workforce by nearly 200 employees [2][5]. - The addition of two FDA-registered, ISO 13485-certified facilities in Galway, Ireland, and Tecate, Mexico, strengthens Quasar's global presence and improves customer proximity [3][4]. Operational Enhancements - The Galway facility will serve as an innovation hub for design & development, focusing on extrusions, braiding, balloons, and complex catheters, while Tecate will provide cost-effective, high-volume manufacturing capabilities [3][5]. - The acquisition enhances Quasar's cleanroom footprint and technical expertise in various medical device technologies, leading to faster development and improved quality control [5][7]. Strategic Positioning - Quasar aims to position itself as a strategic partner to customers, offering a differentiated platform that combines upstream innovation and downstream scalability [4][6]. - The company will collaborate closely with Nordson to ensure a seamless transition for employees, customers, and suppliers [6].